Comparison Overview

LLX Solutions LLC

VS

Zoetis

LLX Solutions LLC

1400 Main St, Waltham, Massachusetts, 02451, US
Last Update: 2025-03-05 (UTC)
Between 800 and 900

Strong

LLX Solutions, a biopharmaceutical services company, provides clinical trial design and Protocol development, statistical analysis, programming, data management and Consulting services to the pharmaceutical, biotechnology, and medical device industries. Its team has proven expertise in supporting global clinical trials for different sizes of companies in the United States in various therapeutic categories such as cardiology, oncology, rare disease, medical devices, pain, infectious diseases, neurology, allergy/immunology, endocrinology/metabolism, gastroenterology and pediatrics. LLX Solutionsโ€™ core competencies are its employees. The key members have over 12 years experience in the industry and have built excellent reputations in the companies they severed. They have been working and providing consultant services for various biotech and pharmaceutical companies such as Wyeth/Pfizer, Shire, Genzyme, Altus, Ariad, Synta, Boston Scientific, etc. With this background, LLX Solutions is committed to provide our clients with the highest quality and timely deliverables. We are dedicated to ensuring that our clients will get the best services from us. The company was founded in 2011 and is headquartered in Waltham, Massachusetts.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 83
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Zoetis

10 Sylvan Way, Parsippany, NJ, 07054, US
Last Update: 2025-03-04 (UTC)

Below Average

Between 400 and 500

The worldโ€™s leading animal health company. Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. Weโ€™ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide โ€“ from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. Community Guidelines: This page is intended for learning more about how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are some guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 11,195
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/llx-solutions-llc.jpeg
LLX Solutions LLC
โ€”
ISO 27001
Not verified
โ€”
SOC 2
Not verified
โ€”
GDPR
No public badge
โ€”
PCI DSS
No public badge
https://images.rankiteo.com/companyimages/zoetis.jpeg
Zoetis
โ€”
ISO 27001
Not verified
โ€”
SOC 2
Not verified
โ€”
GDPR
No public badge
โ€”
PCI DSS
No public badge
Compliance Summary
LLX Solutions LLC
100%
Compliance Rate
0/4 Standards Verified
Zoetis
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for LLX Solutions LLC in 2025.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Zoetis in 2025.

Incident History โ€” LLX Solutions LLC (X = Date, Y = Severity)

LLX Solutions LLC cyber incidents detection timeline including parent company and subsidiaries

Incident History โ€” Zoetis (X = Date, Y = Severity)

Zoetis cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/llx-solutions-llc.jpeg
LLX Solutions LLC
Incidents

No Incident

https://images.rankiteo.com/companyimages/zoetis.jpeg
Zoetis
Incidents

No Incident

FAQ

LLX Solutions LLC company company demonstrates a stronger AI risk posture compared to Zoetis company company, reflecting its advanced AI governance and monitoring frameworks.

Historically, Zoetis company has disclosed a higher number of cyber incidents compared to LLX Solutions LLC company.

In the current year, Zoetis company and LLX Solutions LLC company have not reported any cyber incidents.

Neither Zoetis company nor LLX Solutions LLC company has reported experiencing a ransomware attack publicly.

Neither Zoetis company nor LLX Solutions LLC company has reported experiencing a data breach publicly.

Neither Zoetis company nor LLX Solutions LLC company has reported experiencing targeted cyberattacks publicly.

Neither LLX Solutions LLC company nor Zoetis company has reported experiencing or disclosing vulnerabilities publicly.

Neither LLX Solutions LLC company nor Zoetis company has publicly disclosed detailed information about the number of their subsidiaries.

Zoetis company employs more people globally than LLX Solutions LLC company, reflecting its scale as a Pharmaceutical Manufacturing.

Latest Global CVEs (Not Company-Specific)

Description

pwn.college DOJO is an education platform for learning cybersecurity. In versions up to and including commit 781d91157cfc234a434d0bab45cbcf97894c642e, the /workspace endpoint contains an improper authentication vulnerability that allows an attacker to access any active Windows VM without proper authorization. The vulnerability occurs in the view_desktop function where the user is retrieved via a URL parameter without verifying that the requester has administrative privileges. An attacker can supply any user ID and arbitrary password in the request parameters to impersonate another user. When requesting a Windows desktop service, the function does not validate the supplied password before generating access credentials, allowing the attacker to obtain an iframe source URL that grants full access to the target user's Windows VM. This impacts all users with active Windows VMs, as an attacker can access and modify data on the Windows machine and in the home directory of the associated Linux machine via the Z: drive. This issue has been patched in commit 467db0b9ea0d9a929dc89b41f6eb59f7cfc68bef. No known workarounds exist.

Risk Information
cvss4
Base: 9.5
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:L/SC:H/SI:H/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Adobe Experience Manager versions 11.6 and earlier are affected by a stored Cross-Site Scripting (XSS) vulnerability that could be abused by a low privileged attacker to inject malicious scripts into vulnerable form fields. Malicious JavaScript may be executed in a victimโ€™s browser when they browse to the page containing the vulnerable field. Exploitation of this issue requires user interaction in that a victim must open a malicious link. Scope is changed.

Risk Information
cvss3
Base: 5.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Description

Adobe Experience Manager versions 11.6 and earlier are affected by a stored Cross-Site Scripting (XSS) vulnerability that could be abused by a low privileged attacker to inject malicious scripts into vulnerable form fields. Malicious JavaScript may be executed in a victimโ€™s browser when they browse to the page containing the vulnerable field. Exploitation of this issue requires user interaction in that a victim must open a malicious link. Scope is changed.

Risk Information
cvss3
Base: 5.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Description

Adobe Experience Manager versions 11.6 and earlier are affected by a stored Cross-Site Scripting (XSS) vulnerability that could be abused by a low privileged attacker to inject malicious scripts into vulnerable form fields. Malicious JavaScript may be executed in a victimโ€™s browser when they browse to the page containing the vulnerable field. Exploitation of this issue requires user interaction in that a victim must open a malicious link. Scope is changed.

Risk Information
cvss3
Base: 5.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Description

Adobe Connect versions 12.9 and earlier are affected by a URL Redirection to Untrusted Site ('Open Redirect') vulnerability. An attacker could leverage this vulnerability to redirect users to malicious websites. Exploitation of this issue requires user interaction in that a victim must click on a crafted link.

Risk Information
cvss3
Base: 3.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:N/I:L/A:N